Open AccessLow concentration amino‐bisphosphonates stimulate human keratinocyte proliferation and in vitro wound healing
Author(s) -
Renò Filippo,
Migliario Mario,
Rizzi Manuela,
Invernizzi Marco,
Cisari Carlo,
Cannas Mario
Publication year - 2012
Publication title -
international wound journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.867
H-Index - 63
eISSN - 1742-481X
pISSN - 1742-4801
DOI - 10.1111/j.1742-481x.2011.00905.x
Subject(s) - wound healing , keratinocyte , bisphosphonate , medicine , cell growth , in vitro , matrix metalloproteinase , pharmacology , cell migration , cancer research , microbiology and biotechnology , biochemistry , chemistry , immunology , biology , osteoporosis
Amino‐bisphosphonates (N‐BPs) are widely used to treat a great variety of clinical conditions involving altered calcium metabolism, as well as to prevent bone metastases. The use of N‐BPs, however, display well‐known side effects, including cellular toxicity, mainly at soft tissue and mucosal level, that arise from N‐BPs ability to induce cell apoptosis when administered at clinically relevant concentrations. The aim of this study was to evaluate, in an in vitro wound healing model, the effect of N‐BPs low concentration (10 nM–10 µM) stimulation on keratinocyte cellular behaviour. Human keratinocytes were treated with neridronate and zoledronate, two N‐BPs with different chemical structure and clinical potency, but sharing a common pharmacological target: farnesyl pyrophosphate (FPP) synthase. Surprisingly, at the tested concentrations, both drugs stimulated keratinocytes proliferation, upregulating cytokeratin 5 while downregulating filaggrin expression, and wound healing ability, without any significant effect on matrix metalloproteinase (MMP)‐9 activity. The lack of N‐BPs effect on MMP‐9 activity indicates that wound closure, in our experimental model, is mainly due to an increase in cell proliferation rather than to an increase in cell migration. Therefore, it can be hypothesised that the observed wound healing results could be ascribed to an N‐BPs mediated reduction of FPP endogenous levels, thus suggesting new possible clinical applications for these compounds.